Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Systematic Review

Published on 11 Jan 2024

Comparative efficiency and safety of potassium competitive acid blockers versus Lansoprazole in peptic ulcer: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Yongqi Dong
Hongyan Xu
Zhihuan Zhang
Zhihang Zhou
Qiang Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1304552

6,603 views
9 citations

Systematic Review

Published on 10 Jan 2024

A bibliometric and visual analysis of the use of ustekinumab in Crohn’s disease using CiteSpace

in Gastrointestinal and Hepatic Pharmacology

Yi Chen
Jiaqi Zhang
Junling Wu
Hanwen Zhang
Zhe Luan
Zhizhuang Zhao
Congyong Li
Yiming Zhao
Hu Zhang
Shufang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1322319

3,918 views
5 citations

Original Research

Published on 09 Jan 2024

Dimethyloxalylglycine pretreatment of living donor alleviates both donor and graft liver ischemia-reperfusion injury in rats

in Gastrointestinal and Hepatic Pharmacology

Degong Jia
Minjie Zhao
Jiefu Luo
Shengwei Li
Jianping Gong
Mingxiang Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1341575

1,572 views

Editorial

Published on 08 Jan 2024

Editorial: Women in gastrointestinal and hepatic pharmacology 2022

in Gastrointestinal and Hepatic Pharmacology

Eleonora Lai
Jessica Williams
Raquel Abalo
Daniela Gabbia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1359135

989 views

Systematic Review

Published on 08 Jan 2024

Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Xin Chi
Xiu Sun
Danying Cheng
Shunai Liu
Calvin Q. Pan
Huichun Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1274261

2,180 views
2 citations

Original Research

Published on 05 Jan 2024

Role of symbiotic microbiota dysbiosis in the progression of chronic kidney disease accompanied with vascular calcification

in Gastrointestinal and Hepatic Pharmacology

Mengying Sun
Yilong Fang
Jianhua Zheng
Guojuan Shi
Junli Guo
Xinzhou Zhang
Rui Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1306125

3,919 views
5 citations

Original Research

Published on 04 Jan 2024

Unlocking the hepatoprotective potential of the parasitic plant Orobanche foetida Poir. aqueous extract against CCl4-induced liver injury in rat

in Gastrointestinal and Hepatic Pharmacology

Arij Bedoui
Afoua Mufti
Anouar Feriani
Hanene Baccari
Amal Bouallegue
Mohamed Kharrat
Mansour Sobeh
Moez Amri
Zouhaier Abbes

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1320062

3,352 views
5 citations

Original Research

Published on 21 Dec 2023

Serum metabolomics characteristics and fatty-acid-related mechanism of cirrhosis with histological response in chronic hepatitis B

in Gastrointestinal and Hepatic Pharmacology

Hai-Na Fan
Zhi-Min Zhao
Kai Huang
Xiao-Ning Wang
Yun-Kai Dai
Cheng-Hai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1329266

2,676 views
3 citations

Review

Published on 15 Dec 2023

Macrophage cytotherapy on liver cirrhosis

in Gastrointestinal and Hepatic Pharmacology

Dabing Ping
Yuan Peng
Xudong Hu
Chenghai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265935

6,302 views
2 citations

Systematic Review

Published on 13 Dec 2023

Effect of potassium-competitive acid blockers on human gut microbiota: a systematic review and meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Meng-Ling Ouyang
Shu-Peng Zou
Qian Cheng
Xuan Shi
Ya-Zheng Zhao
Ming-Hui Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1269125

2,872 views
5 citations

Review

Published on 12 Dec 2023

Research progress of traditional Chinese medicine in improving hepatic fibrosis based on inhibiting pathological angiogenesis

in Gastrointestinal and Hepatic Pharmacology

Zhen Li
Junfeng Zhu
Hao Ouyang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1303012

3,699 views
8 citations

Original Research

Published on 08 Dec 2023

Cholecystectomy is associated with a higher risk of irritable bowel syndrome in the UK Biobank: a prospective cohort study

in Gastrointestinal and Hepatic Pharmacology

Jinyu Zhao
Liang Tian
Bin Xia
Ningning Mi
Qiangsheng He
Man Yang
Danni Wang
Siqing Wu
Zijun Li
Shiyong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244563

10,304 views
5 citations

Correction

Published on 07 Dec 2023

Corrigendum: Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis

in Gastrointestinal and Hepatic Pharmacology

Jin Xiao
Yan-ni Zhou
Yan-lin Yang
Li He
Ke-kai Wang
Min Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1330698

676 views

Mini Review

Published on 01 Dec 2023

The regulatory role and mechanism of exosomes in hepatic fibrosis

in Gastrointestinal and Hepatic Pharmacology

Youli Yao
Da Chen
Zengchang Yue

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1284742

3,121 views
3 citations

Original Research

Published on 22 Nov 2023

Solanum aethiopicum L. from the Basilicata region as a source of specialized metabolites with promising anti-obesity effects: phytochemical characterization and in vivo investigation in high fat diet-fed mice

in Gastrointestinal and Hepatic Pharmacology

Maria Ponticelli
Laura Hidalgo-García
Patricia Diez-Echave
Teresa Vezza
Miguel Romero
Iñaki Robles-Vera
Juan Duarte
Filomena De Biasio
Domenico Gorgoglione
Ludovica Lela

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1306135

3,506 views
1 citation

Original Research

Published on 20 Nov 2023

Increased sinusoidal export of drug glucuronides is a compensative mechanism in liver cirrhosis of mice

in Gastrointestinal and Hepatic Pharmacology

Rebekka Fendt
Ahmed Ghallab
Maiju Myllys
Ute Hofmann
Reham Hassan
Zaynab Hobloss
Daniela González
Lisa Brackhagen
Rosemarie Marchan
Karolina Edlund

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1279357

2,295 views